Home / David L. Joffe, BSPharm, CDE, FACA (page 27)

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA
(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

July 21, 2016

The dust has settled from the ADA scientific sessions in New Orleans and we have had time to look at what we learned about SGLT-2 Inhibitors. There were at least 40 posters on how they work and what they can do, but there was not a whole lot about clinical use. …

Read More »

Over the last 7 years we have heard all about the benefits of GLP-1 analogs. One of the benefits that is often touted is the increase in first phase insulin release. In simple terms, we define this as “the quick release of insulin at the first bite of food,” but …

Read More »

July 16, 2016

When I was was doing a lot of diabetes management and pump starts, U-500 was always a fear causer for many medical professionals. Part of this came from problems with the conversion from a U-100 dose to an equivalent U-500 dose. Even though you simply divided the unit dose by …

Read More »

July 12, 2016

Pyruvate cycling pathway is a term I have not heard in many years. When I was in pharmacy school, I remember our Medicinal Chemistry professor posting a slide on the overhead, and telling us if we learned this by the end of the semester we would pass the class. Although …

Read More »

July 9, 2016

Sixteen years ago when Steve and I started this newsletter, we were sending it out to 30 pharmacists we knew. As more and more of you started subscribing and sharing our site and newsletter with others, I would sometimes sit at my desk in awe of what we had accomplished …

Read More »

July 5, 2016

This past week it seems that the genomic testing company 23&ME has been on an advertising blitz. Maybe they feel that Independence Day is a great time for people to think about their heritage. It was interesting that after one of their commercials, there was one from a large cancer …

Read More »

July 2, 2016

I just did a CE program for consultant pharmacists in Lake Mary, Florida. We were discussing the reasons why we may not try to work to perfection with our older patients. One of my colleagues brought up the 5-star ratings and how one of the measurements had to do with …

Read More »

June 28, 2016

Typically our diabetes patients have changes in vision and they totally ignore them. They blame it on age, environment, old glasses and any other excuse. We as medical professionals don’t stress the possible changes enough because we are more focused on things like neuropathy and kidney failure. This means that …

Read More »

June 25, 2016

Normally when I sit down to prepare the editor’s desk, I read through the articles we are featuring and think about what happened in the past week in the world of diabetes and healthcare; then I fashion my comments to encourage you to read our entire newsletter. This week I don’t …

Read More »

Two weeks ago, I gave a presentation to the Florida Chapter of the American Association of Consultant Pharmacists. The focus of the presentation was on the team concept for diabetes management and all the different professionals that play a role. One part of the presentation was about the new insulins …

Read More »